Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print
  • Editorial Calendar 19-20
BW Businessworld

Novartis Third-Quarter Core Net Income Rises To $3.47 Billion

The Basel-based company broadened its core operating income growth forecast to low double-digit to mid-teen percentage rate growth, from a low double-digit range previously, while net sales are expected to grow in the mid-single-digit percentage range.

Photo Credit :

1474268333_swxPPS_Novartis_Pharma_Reu.jpg

Swiss drugmaker Novartis said on Tuesday that third-quarter core net income was $3.47 billion, up from $3.21 billion a year ago.

Analysts polled by Refinitiv had, on average, forecast $3.2 billion.

For 2020, the Basel-based company broadened its core operating income growth forecast to low double-digit to mid-teen percentage rate growth, from a low double-digit range previously, while net sales are expected to grow in the mid-single-digit percentage range.

(Reuters)


Tags assigned to this article:
novartis pharmaceutical Swiss drugmaker